The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical ...

Tirzepatide is more effective than semaglutide for weight loss, according to a new study on GLP-1 medications ; The study was ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...

In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.

McDonald’s said Monday it plans to hire up to 375,000 U.S. restaurant employees this summer, its biggest hiring push in years ...

If a higher body weight is affecting your ability to get around, or you have joint pain from arthritis, it can impair your ...

Only three drugs – Novo Nordisk’s Wegovy and Saxenda, and Eli Lilly’s Zepbound – are actually approved for that purpose. Now, if used correctly, these drugs can be a lifeline for patients.

NBC News medical contributor Dr. Natalie Azar and TODAY nutrition and health expert Joy Bauer stop by Studio 1A to talk about the benefits of the nutrient magnesium and ways you can incorporate it ...

While Carson Daly is on the West Coast with “The Voice,” he shares a special video message for Blake Shelton filling in on ...

A KFF survey from 2024 found people had superior weight loss results on Zepbound compared to Wegovy, ...